Literature DB >> 33488350

Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.

Yan Li1, Sean K Sethi2,3,4, Chunyan Zhang5, Yanwei Miao6, Kiran Kumar Yerramsetty7, Vinay Kumar Palutla7, Sara Gharabaghi3, Chengyan Wang8, Naying He1, Jingliang Cheng5, Fuhua Yan1, Ewart Mark Haacke1,2,3,4.   

Abstract

PURPOSE: To evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter (DGM) of the human brain using subjects from multiple sites; and to establish a susceptibility baseline as a function of age for each DGM structure using both a global and regional iron analysis.
METHODS: Data from 623 healthy adults, ranging from 20 to 90 years old, were collected across 3 sites using gradient echo imaging on one 1.5 Tesla and two 3.0 Tesla MR scanners. Eight subcortical gray matter nuclei were semi-automatically segmented using a full-width half maximum threshold-based analysis of the QSM data. Mean susceptibility, volume and total iron content with age correlations were evaluated for each measured structure for both the whole-region and RII (high iron content regions) analysis. For the purpose of studying the effect of resolution on QSM, a digitized model of the brain was applied.
RESULTS: The mean susceptibilities of the caudate nucleus (CN), globus pallidus (GP) and putamen (PUT) were not significantly affected by changing the slice thickness from 0.5 to 3 mm. But for small structures, the susceptibility was reduced by 10% for 2 mm thick slices. For global analysis, the mean susceptibility correlated positively with age for the CN, PUT, red nucleus (RN), substantia nigra (SN), and dentate nucleus (DN). There was a negative correlation with age in the thalamus (THA). The volumes of most nuclei were negatively correlated with age. Apart from the GP, THA, and pulvinar thalamus (PT), all the other structures showed an increasing total iron content despite the reductions in volume with age. For the RII regional high iron content analysis, mean susceptibility in most of the structures was moderately to strongly correlated with age. Similar to the global analysis, apart from the GP, THA, and PT, all structures showed an increasing total iron content.
CONCLUSION: A reasonable estimate for age-related iron behavior can be obtained from a large cross site, cross manufacturer set of data when high enough resolutions are used. These estimates can be used for correcting for age related iron changes when studying diseases like Parkinson's disease, Alzheimer's disease, and other iron related neurodegenerative diseases.
Copyright © 2021 Li, Sethi, Zhang, Miao, Yerramsetty, Palutla, Gharabaghi, Wang, He, Cheng, Yan and Haacke.

Entities:  

Keywords:  age-related brain iron; deep gray matter; magnetic resonance imaging; multicenter study; quantitative susceptibility mapping

Year:  2021        PMID: 33488350      PMCID: PMC7815653          DOI: 10.3389/fnins.2020.607705

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  57 in total

1.  Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson Disease.

Authors:  N Pyatigorskaya; B Magnin; M Mongin; L Yahia-Cherif; R Valabregue; D Arnaldi; C Ewenczyk; C Poupon; M Vidailhet; S Lehéricy
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-28       Impact factor: 3.825

Review 2.  Iron and Parkinson's disease: A systematic review and meta-analysis.

Authors:  Giovanni Mostile; Calogero Edoardo Cicero; Loretta Giuliano; Mario Zappia; Alessandra Nicoletti
Journal:  Mol Med Rep       Date:  2017-03-24       Impact factor: 2.952

3.  Intracranial iron distribution and quantification in aceruloplasminemia: A case study.

Authors:  Liche Zhou; Yan Chen; Yan Li; Sara Gharabaghi; Yongsheng Chen; Sean K Sethi; Yiwen Wu; E M Haacke
Journal:  Magn Reson Imaging       Date:  2020-02-27       Impact factor: 2.546

4.  Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan.

Authors:  Wei Li; Bing Wu; Anastasia Batrachenko; Vivian Bancroft-Wu; Rajendra A Morey; Vandana Shashi; Christian Langkammer; Michael D De Bellis; Stefan Ropele; Allen W Song; Chunlei Liu
Journal:  Hum Brain Mapp       Date:  2013-09-13       Impact factor: 5.038

Review 5.  Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.

Authors:  Abdel A Belaidi; Ashley I Bush
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

6.  STrategically Acquired Gradient Echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method.

Authors:  E Mark Haacke; Yongsheng Chen; David Utriainen; Bo Wu; Yu Wang; Shuang Xia; Naying He; Chunyan Zhang; Xiao Wang; M Marcella Lagana; Yu Luo; Ali Fatemi; Saifeng Liu; Sara Gharabaghi; Dongmei Wu; Sean K Sethi; Feng Huang; Taotao Sun; Feifei Qu; Brijesh K Yadav; Xiaoyue Ma; Yan Bai; Meiyun Wang; Jingliang Cheng; Fuhua Yan
Journal:  Magn Reson Imaging       Date:  2019-10-16       Impact factor: 2.546

7.  Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.

Authors:  Thomas Martin Doring; Vanessa Granado; Fernanda Rueda; Andreas Deistung; Juergen R Reichenbach; Gustavo Tukamoto; Emerson Leandro Gasparetto; Ferdinand Schweser
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

8.  Quantitative Susceptibility Mapping in Parkinson's Disease.

Authors:  Christian Langkammer; Lukas Pirpamer; Stephan Seiler; Andreas Deistung; Ferdinand Schweser; Sebastian Franthal; Nina Homayoon; Petra Katschnig-Winter; Mariella Koegl-Wallner; Tamara Pendl; Eva Maria Stoegerer; Karoline Wenzel; Franz Fazekas; Stefan Ropele; Jürgen Rainer Reichenbach; Reinhold Schmidt; Petra Schwingenschuh
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

9.  Regional High Iron in the Substantia Nigra Differentiates Parkinson's Disease Patients From Healthy Controls.

Authors:  Kiarash Ghassaban; Naying He; Sean Kumar Sethi; Pei Huang; Shengdi Chen; Fuhua Yan; Ewart Mark Haacke
Journal:  Front Aging Neurosci       Date:  2019-05-27       Impact factor: 5.750

Review 10.  Brain Iron Accumulation in Atypical Parkinsonian Syndromes: in vivo MRI Evidences for Distinctive Patterns.

Authors:  Jae-Hyeok Lee; Myung-Sik Lee
Journal:  Front Neurol       Date:  2019-02-12       Impact factor: 4.003

View more
  5 in total

Review 1.  Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?

Authors:  Farzaneh Nikparast; Zohreh Ganji; Hoda Zare
Journal:  BMC Neurosci       Date:  2022-07-28       Impact factor: 3.264

2.  Quantifying Brain Iron in Hereditary Hemochromatosis Using R2* and Susceptibility Mapping.

Authors:  S K Sethi; S Sharma; S Gharabaghi; D Reese; Y Chen; P Adams; M S Jog; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2022-07       Impact factor: 4.966

Review 3.  Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?

Authors:  Farzaneh Nikparast; Zohreh Ganji; Mohammad Danesh Doust; Reyhane Faraji; Hoda Zare
Journal:  Insights Imaging       Date:  2022-04-13

4.  Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging.

Authors:  Nikkita Khattar; Curtis Triebswetter; Matthew Kiely; Luigi Ferrucci; Susan M Resnick; Richard G Spencer; Mustapha Bouhrara
Journal:  Neuroimage       Date:  2021-06-15       Impact factor: 7.400

5.  R2* and quantitative susceptibility mapping in deep gray matter of 498 healthy controls from 5 to 90 years.

Authors:  Sarah Treit; Nashwan Naji; Peter Seres; Julia Rickard; Emily Stolz; Alan H Wilman; Christian Beaulieu
Journal:  Hum Brain Mapp       Date:  2021-06-29       Impact factor: 5.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.